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Sex steroid production and signalling, which starts in utero, is tightly controlled throughout life. 
Surges in sex hormones at critical junctures during pre- and post-natal development, as well as 
during the pubertal period, alter growth and behaviour and determine reproductive success. Sex 
hormones continue to shape physiological systems including cardiorespiratory function throughout 
adult life in both sexes. The menopause strikingly reveals the extensive protective effects of female 
sex steroid hormones, illustrating important roles beyond reproduction. The incidence of sleep-
disordered breathing and cardiovascular disease rises dramatically in post-menopausal women.  
Obstructive sleep apnoea, characterised by recurrent occlusions of the pharyngeal airway giving rise 
to repeated bouts of intermittent hypoxia, is described as an oxidative stress disorder wherein 
aberrant redox signalling can exacerbate disordered breathing and perpetuate co-morbidities such 
as hypertension. Antioxidants modulate the redox environment to prevent oxidative stress and have 
been explored as putative adjunctive therapies to ameliorate obstructive sleep apnoea.  
Progesterone is a lipophilic sex steroid and neurosteroid that is recognised as a ventilatory stimulant, 
owing to early clinical reports of hyperventilation during pregnancy and the luteal phase of the 
oestrus cycle as well as the resultant loss of cyclic ventilatory variability associated with the 
menopause. Sleep apnoea during pregnancy has been associated with lower circulating levels of 
progesterone compared with pregnant women without the condition.  Of interest, the progesterone 
receptor agonist chlormadinone acetate was shown to decrease the apnoea hypopnoea index and 
hypoxic episodes in a small mixed-sex study (Kimura et al., 1989).  
Oestrogen and progesterone exert their actions by acting on their endogenous receptors, but they 
can also enhance antioxidant capacity either directly or indirectly. Antioxidants such as superoxide 
dismutase have been shown to decrease with age in rats, but progesterone therapy in aged rats 
increases the activity of superoxide dismutase. In addition, sex hormones can modulate a wide 
variety of signalling cascades, for example, enhancing insulin-like growth factor-1 and facilitating 
orexigenic signalling, both of which are inversely correlated with obstructive sleep apnoea. 
Receptors for progesterone and its metabolites are expressed at multiple sites of the integrated 
cardio-respiratory system. Moreover, progesterone and its metabolites stimulate pleiotropic 
receptors in the brain such as GABAA, nicotinic, 5-HT and glycine receptors that can modulate the 
control of breathing. Harnessing the benefits of hormones like progesterone is a potentially 
promising avenue of research in the search for effective pharmacotherapies for sleep-disordered 
breathing. 
In this issue of Experimental Physiology, Joseph et al. (2020) examine the effects of supplemental 
progesterone on chronic intermittent hypoxia (CIH)-induced oxidative stress and the capacity to 
ameliorate the deleterious effects of exposure to CIH on cardiorespiratory function. Female rats 
underwent ovariohysterectomy and osmotic pump implantation for the delivery of vehicle or 
progesterone. Three experimental groups were established: vehicle treatment with subsequent 
exposure to normoxia or CIH, and progesterone treatment with subsequent exposure to CIH. The 
authors assessed breathing using whole body plethysmography. In addition, pro-oxidant NADPH 
oxidase activity and antioxidant enzyme activities of superoxide dismutase and glutathione 
peroxidase were determined in brainstem and cerebral cortex.   
Joseph et al. (2020) reported CIH-induced oxidative stress in the cerebral cortex owing to 
upregulation of NADPH oxidase and decreases in antioxidant capacity. Progesterone 
supplementation reduced oxidative stress, preventing CIH-induced depletion of superoxide 
dismutase and glutathione peroxidase. Brainstem superoxide dismutase activity was unchanged 
following CIH, however NADPH oxidase activity was increased and this was prevented by 
progesterone supplementation. Progesterone protected against CIH-induced apnoeas, 
notwithstanding hyperventilation at rest evidenced by an elevated ventilatory equivalent (VE/VCO2). 
Interestingly, CIH-induced increases in hypoxic ventilatory responses were blocked by progesterone; 
however, CIH-induced hypertension was unaffected. 
Chronic progesterone administration has been previously demonstrated to reduce the incidence of 
apnoea and increase the hypoxic ventilatory response in neonatal rat pups (Joseph et al., 2018, 
Lefter et al., 2007). It is generally considered that CIH-induced facilitation of afferent signalling from 
the carotid body to the brainstem is a major driver of CIH-induced cardiorespiratory morbidity. 
Progesterone could potentially reduce the oxidative environment within the CIH-exposed carotid 
body thereby preventing sensory facilitation, which would be consistent with the observed 
restoration of hypoxic ventilatory responsiveness and the decreased incidence of apnoea in CIH-
exposed rats (Joseph et al. 2020), especially if one considers that enhanced carotid body 
chemoreflexes are the primary cause of destabilized breathing associated with exposure to CIH. If so, 
however, then one might also have expected attenuation of CIH-induced increases in blood 
pressure, since increased carotid body chemoreflex control of sympathetic outflow is considered the 
major causal factor elaborating CIH-induced hypertension. 
The findings suggest that ventilatory outcomes in the study by Joseph et al. (2020) may have arisen 
from progesterone signalling and/or antioxidant effects of the steroid hormone primarily within CNS 
structures modulating breathing. Of relevance, exposure to CIH has been shown to cause oxidative 
stress within rhythmogenic sites of the brainstem, causing dysrhythmic respiratory motor bursting, 
which proved amenable to antioxidant intervention. It is also conceivable that redox modulation at 
other sites within the neural circuitry regulating breathing may have contributed to the respiratory 
phenotype in CIH-exposed rats. 
Recent studies have drawn focus to the potential role of the microbiota-gut-bran axis in the 
regulation of respiratory homeostasis (Lucking et al., 2018, O'Connor et al., 2019). Intriguingly, 
exposure to CIH and progesterone both independently alter gut microbiota composition. Thus, 
whereas redox disturbances at one or more sites within the integrative respiratory network most 
likely explains CIH-induced respiratory morbidity, there may also be contributions related to altered 
brainstem neurochemistry arising from changes to the gut microbiota (Lucking et al., 2018), which 
could be influenced by progesterone supplementation.  
Whereas the lack of efficacy of progesterone supplementation in preventing CIH-induced 
hypertension is disappointing, the sex steroid or perhaps a downstream metabolite proves to be a 
potentially promising therapeutic in the treatment of CIH-induced apnoea. The important findings 
from the study by Joseph et al. (2020) suggest that sex steroids may be beneficial as an intervention 
for disordered breathing in various scenarios, and particularly for post-menopausal women. 
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